4.6 Article

Alternative Genetic Diagnoses in Axenfeld-Rieger Syndrome Spectrum

Journal

GENES
Volume 14, Issue 10, Pages -

Publisher

MDPI
DOI: 10.3390/genes14101948

Keywords

Axenfeld-Rieger anomaly; Axenfeld-Rieger syndrome; USP9X; JAG1; CDK13; BCOR; HCCS; AMELX

Ask authors/readers for more resources

Axenfeld-Rieger anomaly is an ocular disorder associated with other systemic abnormalities. This study identified pathogenic variants in nine families affecting five different genes/regions. USP9X and JAG1 were the most commonly mutated genes associated with the disorder. Variants in CDK13, BCOR, and an X chromosome deletion were also found to be linked with Axenfeld-Rieger syndrome.
Axenfeld-Rieger anomaly (ARA) is a specific ocular disorder that is frequently associated with other systemic abnormalities. PITX2 and FOXC1 variants explain the majority of individuals with Axenfeld-Rieger syndrome (ARS) but leave similar to 30% unsolved. Here, we present pathogenic/likely pathogenic variants in nine families with ARA/ARS or similar phenotypes affecting five different genes/regions. USP9X and JAG1 explained three families each. USP9X was recently linked with syndromic cognitive impairment that includes hearing loss, dental defects, ventriculomegaly, Dandy-Walker malformation, skeletal anomalies (hip dysplasia), and other features showing a significant overlap with FOXC1-ARS. Anterior segment anomalies are not currently associated with USP9X, yet our cases demonstrate ARA, congenital glaucoma, corneal neovascularization, and cataracts. The identification of JAG1 variants, linked with Alagille syndrome, in three separate families with a clinical diagnosis of ARA/ARS highlights the overlapping features and high variability of these two phenotypes. Finally, intragenic variants in CDK13, BCOR, and an X chromosome deletion encompassing HCCS and AMELX (linked with ocular and dental anomalies, correspondingly) were identified in three additional cases with ARS. Accurate diagnosis has important implications for clinical management. We suggest that broad testing such as exome sequencing be applied as a second-tier test for individuals with ARS with normal results for PITX2/FOXC1 sequencing and copy number analysis, with attention to the described genes/regions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available